Endurance Wealth Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$59K Sell
1,500
-1,200
-44% -$42.4K 0.01% 319
2023
Q1
$66K Hold
2,700
0.01% 315
2022
Q4
$58K Hold
2,700
0.01% 309
2022
Q3
$48K Hold
2,700
0.01% 329
2022
Q2
$25K Hold
2,700
﹤0.01% 392
2022
Q1
$45K Hold
2,700
0.01% 361
2021
Q4
$27K Hold
2,700
﹤0.01% 419
2021
Q3
$30K Hold
2,700
﹤0.01% 406
2021
Q2
$19K Hold
2,700
﹤0.01% 459
2021
Q1
$16K Hold
2,700
﹤0.01% 484
2020
Q4
$18K Buy
2,700
+1,200
+80% +$7.68K ﹤0.01% 435
2020
Q3
$8K Hold
1,500
﹤0.01% 509
2020
Q2
$8K Hold
1,500
﹤0.01% 487
2020
Q1
$5K Hold
1,500
﹤0.01% 476
2019
Q4
$13K Hold
1,500
﹤0.01% 405
2019
Q3
$2K Hold
1,500
﹤0.01% 495
2019
Q2
$2K Hold
1,500
﹤0.01% 449
2019
Q1
$2K Hold
1,500
﹤0.01% 453
2018
Q4
$2K Hold
1,500
﹤0.01% 450
2018
Q3
$4K Hold
1,500
﹤0.01% 442
2018
Q2
$4K Hold
1,500
﹤0.01% 450
2018
Q1
$4K Hold
1,500
﹤0.01% 472
2017
Q4
$5K Hold
1,500
﹤0.01% 453
2017
Q3
$4K Hold
1,500
﹤0.01% 455
2017
Q2
$4K Hold
1,500
﹤0.01% 460
2017
Q1
$5K Hold
1,500
﹤0.01% 451
2016
Q4
$7K Hold
1,500
﹤0.01% 421
2016
Q3
$66K Hold
1,500
0.01% 250
2016
Q2
$77K Buy
1,500
+500
+50% +$24.8K 0.01% 232
2016
Q1
$42K Hold
1,000
0.01% 277
2015
Q4
$79K Hold
1,000
0.02% 234
2015
Q3
$42K Hold
1,000
0.01% 287
2015
Q2
$52K Buy
+1,000
New +$49.7K 0.01% 267

Other funds holding ISEE

Endurance Wealth Management's ISEE Position: Q2 2023 in Review

Endurance Wealth Management reduced its IVERIC bio, Inc. Common Stock (ISEE) stake by 44% in Q2 2023, selling an estimated $42.4K and leaving 1,500 shares worth $59K. The position accounts for 0.01% of the portfolio, ranked #319.

Endurance Wealth Management first reported a position in ISEE in Q2 2015 and has held it in 33 quarters since. The position peaked at $79K in Q4 2015. 255 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Endurance Wealth Management held 1,500 shares of IVERIC bio, Inc. Common Stock worth $59K as of Q2 2023.
  • Endurance Wealth Management sold 1,200 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $42.4K.
  • IVERIC bio, Inc. Common Stock made up 0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #319 holding.
  • Endurance Wealth Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and has held it in 33 quarters since.
  • Endurance Wealth Management's IVERIC bio, Inc. Common Stock position peaked at $79K in Q4 2015.
  • 255 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.